Similar articles

• [Comparative efficacy and tolerance of atenolol and midodrine in patients with vasovagal syncopes].

  Kuchinskaia EA, Pevzner AV, Vershuta EV, Al'bitskaia KV, Kheĭmets GI, Rogoza AN, Golitsyn SP. Kuchinskaia EA, et al. Ter Arkh. 2006;78(4):64-8. Ter Arkh. 2006. PMID: 16821426 Clinical Trial. Russian.
• Randomized double-blind placebo-controlled multicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase II study.

  Weil EH, Eerdmans PH, Dijkman GA, Tamussino K, Feyereisl J, Vierhout ME, Schmidbauer C, Egarter C, Kölle D, Plasman JE, Heidler H, Abbühl BE, Wein W. Weil EH, et al. Int Urogynecol J Pelvic Floor Dysfunct. 1998;9(3):145-50. doi: 10.1007/BF02001083. Int Urogynecol J Pelvic Floor Dysfunct. 1998. PMID: 9745973 Clinical Trial.
• [Efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope].

  Liu XY, Wang C, Wu LJ, Hu CY, Lin P, Li MX, Cui XL, Xie ZW. Liu XY, et al. Zhonghua Yi Xue Za Zhi. 2009 Jul 28;89(28):1951-4. Zhonghua Yi Xue Za Zhi. 2009. PMID: 19950567 Clinical Trial. Chinese.
• Midodrine. A review of its therapeutic use in the management of orthostatic hypotension.

  McClellan KJ, Wiseman LR, Wilde MI. McClellan KJ, et al. Drugs Aging. 1998 Jan;12(1):76-86. doi: 10.2165/00002512-199812010-00007. Drugs Aging. 1998. PMID: 9467688 Review.
• Efficacy and safety of midodrine in the treatment of dialysis-associated hypotension.

  Perazella MA. Perazella MA. Expert Opin Drug Saf. 2003 Jan;2(1):37-47. doi: 10.1517/14740338.2.1.37. Expert Opin Drug Saf. 2003. PMID: 12904123 Review.